Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma. - Stuver R; Horwitz SM; Advani RH; Vose JM; Lee HJ; Mehta-Shah N; Zain JM; Haverkos B; Lechowicz MJ; Moskowitz AJ; Pham LQ; Leyden E; et al. (British journal of haematology, 2023)